These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 31006778)
1. [Central nervous system atypical teratoid/rhabdoid tumor without loss of nuclear expression of INI1]. Ryzhova MV; Kadyrov SU; Kumirova EV; Shishkina LV; Nikitin PV; Panina TN; Shibaeva IV; Shugay SV; Starovoytov DV; Sycheva RV; Zubova IV Arkh Patol; 2019; 81(2):36-42. PubMed ID: 31006778 [TBL] [Abstract][Full Text] [Related]
2. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4). Bookhout C; Bouldin TW; Ellison DW Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065 [TBL] [Abstract][Full Text] [Related]
3. Loss of BRG1 ( Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913 [TBL] [Abstract][Full Text] [Related]
5. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases. Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994 [TBL] [Abstract][Full Text] [Related]
6. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635 [TBL] [Abstract][Full Text] [Related]
10. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant. Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939 [TBL] [Abstract][Full Text] [Related]
11. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Ramalingam P; Croce S; McCluggage WG Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089 [TBL] [Abstract][Full Text] [Related]
13. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Biegel JA; Fogelgren B; Wainwright LM; Zhou JY; Bevan H; Rorke LB Genes Chromosomes Cancer; 2000 May; 28(1):31-7. PubMed ID: 10738300 [TBL] [Abstract][Full Text] [Related]
14. Pathology and diagnosis of SMARCB1-deficient tumors. Margol AS; Judkins AR Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033 [TBL] [Abstract][Full Text] [Related]
15. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous. Pinto EM; Hamideh D; Bahrami A; Orr BA; Lin T; Pounds S; Zambetti GP; Pappo AS; Gajjar A; Agnihotri S; Broniscer A Acta Neuropathol; 2018 Aug; 136(2):315-326. PubMed ID: 29428974 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors. Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336 [TBL] [Abstract][Full Text] [Related]
17. Secondary INI1-deficient rhabdoid tumors of the central nervous system: analysis of four cases and literature review. Nobusawa S; Nakata S; Yoshida Y; Yamazaki T; Ueki K; Amano K; Yamamoto J; Miyahara M; Sugai T; Nakazato Y; Hirato J; Yokoo H Virchows Arch; 2020 May; 476(5):763-772. PubMed ID: 31707588 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology. Judkins AR Adv Anat Pathol; 2007 Sep; 14(5):335-9. PubMed ID: 17717433 [TBL] [Abstract][Full Text] [Related]
19. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189 [TBL] [Abstract][Full Text] [Related]
20. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]